Bharat Biotech's Covaxin shows 77.8 pc efficacy in Phase III...
DCGI's expert panel to review Phase III data of Covaxin today
New Delhi [India], June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator will discuss...
Bharat Biotech has submitted Covaxin's Phase III trial data...
New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech...
India to favour discussions on 'vaccine passports' with...
New Delhi [India], June 17 (ANI): While countries like Japan deciding to issue "vaccine passports" as proof of...
Bharat Biotech, WHO pre-submission meeting on June 23: WHO
New Delhi [India], June 17 (ANI): Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on...
No quarantine for Covishield vaccinated Indians in South...
New Delhi [India], June 16 (ANI): Indians vaccinated with double doses of the Covishield vaccine will be able to...
Patra attacks Congress, accuses it of creating doubts about...
New Delhi [India], June 16 (ANI): BJP leader Sambit Patra on Wednesday attacked the Congress over remarks of its...
Covid-19: No newborn calf serum in final Covaxin product,...
New Delhi [India], June 16 (ANI): The Union Health Ministry on Wednesday said that newborn calf serum is not an...
Rs 150 per dose is not sustainable in long run: Bharat...
COVID-19: Owaisi targets Centre over official death toll,...
Hyderabad (Telangana) [India], June 15 (ANI): Alleging that India's death toll due to COVID is 'five to six'...
AIIMS Delhi to start screening children aged 6-12 yrs for...
New Delhi [India], June 14 (ANI): The screening of children aged 6 to 12 years for the clinical trials of...
Bharat Biotech to undertake clinical trials in US
New Delhi [India], June 12 (ANI): India's first indigenous COVID-19 vaccine manufacturer Bharat Biotech on...
Copyright © aninews.in | All Rights Reserved.